BCV-193N was positively assessed in the Scientific Advice Meeting
Coronavirus vaccine development at baseclick Vaccine GmbH
Neuried, Germany, October 29th, 2021 – the German company baseclick Vaccine GmbH presented its preclinical data to the Paul Ehrlich Institute in a Scientific Advice Meeting, the outline for the production of its sugar-modified mRNA vaccine and phase I clinical study.